MicroRNA-126: a promising novel biomarker in peripheral blood for diabetic retinopathy.

about

MicroRNA and Microvascular Complications of Diabetes.Serum Extracellular Superoxide Dismutase Is Associated with Diabetic Retinopathy Stage in Chinese Patients with Type 2 Diabetes Mellitus.

P2860

Q55262853-3F6FB3A1-5A17-4EFB-9AA7-EA6F6E9E436E Q55365452-0A50869B-A583-46E0-ABE2-8D9FD9EB6FD0

P2860

MicroRNA-126: a promising novel biomarker in peripheral blood for diabetic retinopathy.

Item

http://www.wikidata.org/entity/Q41942974

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

MicroRNA-126: a promising novel biomarker in peripheral blood for diabetic retinopathy.

@en

type

Item

label

MicroRNA-126: a promising novel biomarker in peripheral blood for diabetic retinopathy.

@en

prefLabel

MicroRNA-126: a promising novel biomarker in peripheral blood for diabetic retinopathy.

@en

P1476

MicroRNA-126: a promising novel biomarker in peripheral blood for diabetic retinopathy.

@en

P2093

Han-Chun Xu

http://www.w3.org/2001/XMLSchema#string

Li-Li Qin

http://www.w3.org/2001/XMLSchema#string

Mei-Xia An

http://www.w3.org/2001/XMLSchema#string

Yan-Li Liu

http://www.w3.org/2001/XMLSchema#string

Zhi-Qing Lu

http://www.w3.org/2001/XMLSchema#string

P2860

The role of miR-126 in embryonic angiogenesis, adult vascular homeostasis, and vascular repair and its alterations in atherosclerotic disease.

Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results.

Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.

Diabetic retinopathy: An update on treatment.

Homocysteine serum levels in diabetic patients with non proliferative, proliferative and without retinopathy.

Prevention and treatment of diabetic retinopathy: evidence from clinical trials and perspectives.

Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.

Global population-specific variation in miRNA associated with cancer risk and clinical biomarkers

Long-term effects of ranibizumab on diabetic retinopathy severity and progression.

[Evaluate the effectiveness of laser therapy in the treatment of diabetic maculopathy].

P304

530-534

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18240/IJO.2017.04.05

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28503423

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5406628

http://www.w3.org/2001/XMLSchema#string

MicroRNA-126: a promising novel biomarker in peripheral blood for diabetic retinopathy.

about

P2860

P2860

MicroRNA-126: a promising novel biomarker in peripheral blood for diabetic retinopathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932